Evolution of goal setting and attainment over repeated cycles of botulinum toxin A for upper limb spasticity in real-life clinical practice: longitudinal analyses from the observational ULIS-III cohort study
Journal of Rehabilitation Medicine · 2026
DOI: 10.2340/jrm.v58.45139 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Rehabilitation Medicine, 2026. Verfasst von Lynne Turner-Stokes und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Palliative Care, Policy and Rehabilitation, Faculty of Nursing, Midwifery and Palliative Care, King's College London, London, United Ki…. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Muscle Spasticity, Neuromuscular Agents, Upper Extremity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
This post-hoc analysis evaluated how goal attainment evolved over repeated cycles of botulinum toxin A (BoNT-A) treatment in adults with upper-limb spasticity.
Methods
ULIS-III (NCT02454803) was a 2-year observational study involving adults treated with BoNT-A. The analysis included 538 patients who received ≥ 4 BoNT-A injection cycles and had Goal Attainment Scaling (GAS) assessments for each of the first 4 cycles. GAS T-scores were used to measure treatment response. Multivariate models assessed predictors of achieving a GAS T-score ≥ 50 and being in the top tertile (best) of responders.
Results
Patients generally maintained consistent goal domains across cycles. Mean change in GAS T-scores remained above the minimal clinically important difference of 10 throughout. The proportion of patients achieving a GAS T-score ≥ 50 increased from 64.5% in Cycle 1 to 75.8% in Cycle 4. Use of injection guidance techniques significantly increased the odds of achieving treatment goals (OR 1.92; 95% CI 1.45–2.55) and being a “best” responder (OR 2.44; 95% CI 1.47–4.06). Higher BoNT-A doses were also associated with better outcomes.
Conclusions
Repeated BoNT-A treatment supports sustained goal attainment in upper limb spasticity. Success rates improve with each cycle, particularly when guided injection techniques are used.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Palliative Care, Policy and Rehabilitation, Faculty of Nursing, Midwifery and Palliative Care, King's College London, London, United Kingdom; Regional Hyper-acute Rehabilitation Unit, Northwick Park Hospit…
- Neurorehabilitation, Gailtal-Klinik, Hermagor, Austria.
- Centro de Medicina de Reabilitaçãode Alcoitão, Serviço de Reabilitação de adultos 3, Estoril, Portugal.
- Department of Biometry, Ipsen, Paris, France.
- Medical Affairs, Ipsen, Munich, Germany.
Zitieren
APA
Turner-Stokes, L., Fheodoroff, K., Jacinto, J., Beneteau, M., Maisonobe, P., Hannes, C., & Ashford, S. (2026). Evolution of goal setting and attainment over repeated cycles of botulinum toxin A for upper limb spasticity in real-life clinical practice: longitudinal analyses from the observational ULIS-III cohort study. Journal of Rehabilitation Medicine. https://doi.org/10.2340/jrm.v58.45139
Vancouver
Turner-Stokes L, Fheodoroff K, Jacinto J, Beneteau M, Maisonobe P, Hannes C, et al. Evolution of goal setting and attainment over repeated cycles of botulinum toxin A for upper limb spasticity in real-life clinical practice: longitudinal analyses from the observational ULIS-III cohort study. Journal of Rehabilitation Medicine. 2026. doi:10.2340/jrm.v58.45139
BibTeX
@article{TurnerStokes2026,
author = {Turner-Stokes, Lynne and Fheodoroff, Klemens and Jacinto, Jorge and Beneteau, Mathieu and Maisonobe, Pascal and Hannes, Christian and Ashford, Stephen},
title = {Evolution of goal setting and attainment over repeated cycles of botulinum toxin A for upper limb spasticity in real-life clinical practice: longitudinal analyses from the observational ULIS-III cohort study},
journal = {Journal of Rehabilitation Medicine},
year = {2026},
doi = {10.2340/jrm.v58.45139}
}
EUVIMED